Open AccessAlpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks after interferon-based therapy predict hepatocellular carcinoma development
Author(s) -
Satoshi Shakado,
Shotaro Sakisaka,
Kazuaki Chayama,
Takeshi Okanoue,
Joji Toyoda,
Namiki Izumi,
Akihiro Matsumoto,
Tetsuo Takehara,
Akio Ido,
Yoichi Hiasa,
Kentaro Yoshioka,
Hideyuki Nomura,
Yoshiyuki Ueno,
Masataka Seike,
Hiromitsu Kumada
Publication year - 2015
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v7.i27.2757
Subject(s) - medicine , ribavirin , hepatocellular carcinoma , gastroenterology , cirrhosis , odds ratio , incidence (geometry) , hepatitis c virus , prothrombin time , alpha fetoprotein , hepatitis c , alpha interferon , interferon , virus , immunology , physics , optics
To investigate risk factors for development of hepatocellular carcinoma (HCC) in patients with hepatitis C virus-related liver cirrhosis (LC-C).